Summary The ability of a highly sensitive gel immunodiffusion technique to detect faecal occult blood in control subjects and in patients with colorectal carcinoma, was compared to that of Hemoccult II. In 1,200 samples from 200 control subjects, 3.3% were positive by the immunological technique, 5.0% by Hemoccult II with rehydration and 2.3% without rehydration, representing 7.5%, 10.5% and 5.0% of subjects, respectively. A total of 2 carcinomas and 6 polyps were detected in the 27 positive subjects. (Doran & Hardcastle, 1982) . The proportion of false negative results can be diminished by using kits of higher sensitivity or by preliminary rehydration of the faecal specimens, but both give an increased proportion of false positive results (Frommer & Logue, 1981; Winawer et al., 1980 
Screening populations for colorectal carcinoma by detection of faecal occult blood has been increasing over the last decade. Faecal blood has been detected by chemical techniques which depend on the pseudo-peroxidase activity of haemoglobin. These techniques are not specific for bleeding from the gastrointestinal tract, since vegetables with pseudo-peroxidase activity and dietary animal haemoglobin and myoglobin can give false positive reactions (Bassett & Goulston, 1980; . Patients are advised to refrain from eating certain foodstuffs containing pseudo-peroxidases during stool collection, thereby reducing (but not eliminating) false positive results. These restrictions however, are inconvenient and may reduce patient acceptance.
Some of the commercially available detection kits have a sensitivity for blood (e.g. about 200mg Hb lOOg-1 faeces from Hemoccult II (Frommer & Logue, 1981) which have been chosen to prevent an excessive number of false positive results. However, this is achieved at the expense of an increased number of false negative results as is seen in the false negative rate of about 30% with Hemoccult II (Doran & Hardcastle, 1982) . The proportion of false negative results can be diminished by using kits of higher sensitivity or by preliminary rehydration of the faecal specimens, but both give an increased proportion of false positive results (Frommer & Logue, 1981; Winawer et al., 1980 (Table II) showed that 2 had carcinomas and 4 had polyps. The proportion of true positive results (carcinomas and polyps) was similar for immunological and rehydrated Hemoccult II techniques (3%) and greater than that for Hemoccult II with rehydration (2%). However, both for samples and subjects the proportion of false positive results from Hemoccult II with rehydration was greater than without rehydration (P <0.0025 and P <0.05) and also greater than with the immunological technique (P < 0.05 and P= 0.20).
All 40 patients with colorectal cancer (Table III) Hemoccult II without rehydration detected blood in only 71.8% of the patients, and the proportion (52.1%) of positive samples was less than that on immunological testing (79.2%). Rehydration of samples increased the proportion of positive results for both patients (87.5%) and faecal samples (66.3%) but not to the levels found on immunological testing.
There was no range of haemoglobin concentrations which predominated in the positive samples, although few positive samples were above 1000mg
Hb 100mg-1 faeces. Concentrations of 2.0-10.0mg Hb lOOg-1 faeces were found in 35 (14.6%) of positive specimens (in 16 patients), and 33 (13.8%) specimens in 20 patients had concentrations of 10.0-50.0mg Hb lOOg-1 faeces. The percentage of faecal samples from patients with colorectal carcinoma that were positive at or above various concentrations of faecal haemoglobin is shown in Figure 1 . There was a close inverse relationship between these two parameters. Extrapolation of the regression line to the vertical axis suggests that 100% of faecal samples would be positive at 0.47mg Hb lOOg-1 faeces limit of sensitivity. The effect of the number of stool samples on the proportion of patients having all samples negative on immunological testing (i.e. giving false negative results) is shown on Table IV . Results from various combinations of consecutive stool sample ("blocs") with 1-6 samples were taken from each patient and the results of all patients summed. For example, providing 6 samples could have 3 combinations or blocs of 4 samples i.e. 1-4, 2-5 and 3-6 inclusively. It can be seen that a false negativity rate of zero for patients with colorectal carcinoma was achieved with six faecal samples. Investigations showed a probable cause of bleeding in 6 subjects leaving 9 (4.5%) with false positive results, (although one subject had colonic telangiectases). This value is close to the value of 3.9% found in 76 younger (22-42 y) volunteers (Frommer & Kapparis, 1983b) . This suggests that the frequency of false positive results with this technique does not rise markedly with age. The cause of false positive results in this study may be haemorrhoids, other anal pathology or small polyps and telangiectases missed on colonoscopy. The proportion of 4.5% of subjects with false positive results on immunological testing was only slightly higher than that for Hemoccult II without rehydration and would be small enough to enable follow-up investigations to be undertaken in mass screening programmes. Another study involving young volunteers (22.1 + 4.4 y) on a meat free diet, showed that false positive rates with Hemoccult II increase from 0% to 5.7% by rehydrating faecal samples, these values both being lower than that found for the control group in this study. A diet with a lower peroxidase content, greater adherence to the diet or the lower incidence of anal pathology may all have contributed to the lower positivity rate in the younger population.
The incidence of 1% carcinomas in the control population is much higher than has been found in most screened (and mainly asymptomatic) populations where the incidence has varied between 0.02% and 0.72%. The causes of this may be the greater sensitivity of the immunological technique for demonstrating occult blood, more scrupulous follow-up investigations of positive cases, a greater proportion of subjects with symptoms and/or family history of bowel neoplasms or an older age group. However, one can draw no conclusions from such a comparatively small number of subjects and additional data on incidence of carcinoma in screened populations will have to await evaluation of a larger series. The percentage of subjects in the control group with false negative results for carcinomas and polyps may be the same as in the patient group, but this study cannot give any information on this point. This information is being sought in a separate study, to be published later.
The proportion of patients with carcinomas with detectable blood loss is very similar to other studies using Hemoccult II without and with preliminary rehydration. The sensitivity of the techniques used for detecting blood loss from carcinoma was in the order: immunological > rehydrated > not rehydrated Hemoccult II for both samples and patients. Analysis of the immunological data showed that the more sensitive the detection system, the greater the proportion of faecal samples being positive in a predictable manner. From Figure I it can be seen that a limit of sensitivity of 30mg Hb 1OO gfaeces would result in 53.9% of samples being positive. Songster et al. (1980) obtained 67% positivity at this detection limit. Extrapolation of the regression line in Figure 1 suggests that 100% of faecal samples would be positive with a detection limit of about 0.5mg Hb lOOg-1 faeces, but it is doubtful whether the sensitivity of this system could be increased to this degree.
Fewer positive results are obtained with very small samples because inhomogeneity of blood distribution in the faecal mass results in some areas having much lower than average concentrations. Samples from such areas may be below the limit of detection despite the average concentration being above the limit. Sensitivity of detecting occult blood can be increased markedly by homogenising faeces prior to taking small samples e.g. 1-5mg, for analysis. A similar immunodiffusion technique with a detection limit of 5mg Hb lOOg-1 faeces, but using solutions of homogenised faeces, had 40/40 samples and 14/14 patients positive from carcinomas involving the colon (Williams et al., 1982) . An ELISA technique with a detection limit of 5-10mg Hb lOOg-1 faeces, using homogenised 48 h faecal samples from patients with colorectal carcinoma had 93% (28/30) samples and 95% (18/19) patients positive (Turunen et al., 1984) . Homogenisation of samples of I g or more of faeces, may be useful with hospital patients and some outpatients, but the inconvenience and loss of immunological reactivity of about 58-71% day-' (Frommer & Kapperis, 1983a) make it less suitable for mass screening of medium-risk subjects. Faecal samples smeared immediately onto filter paper however, show a loss of reactivity of less than 2.5% day-1 (Frommer & Kapparis, 1983a) . Increase in sensitivity for bleeding from colorectal carcinoma using homogenised samples was also associated with higher positive rates for control subjects, 3/19 (16%) (Williams et al., 1982) .
In this study it can be demonstrated that 21% of samples of the 40 patients with colorectal carcinoma were negative with the immunological technique. From this it might be deduced that a false negative rate of < 1% (0.21) may be achieved by testing three samples (Frommer & Kapparis, 1983a) . However this involves the assumption that each patient has the same likelihood of 21% of false negative samples, and this did not occur as the proportion of false negative results varied markedly. Table IV shows that 6 samples would be needed to reduce the chance of a false negative result to <1%, assuming these data apply to the general cancer population. We have found that the demand for samples from 6 bowel actions instead of 3, as with Hemoccult II, did not reduce patient compliance.
The optimal number of samples to be provided depends on the level of false negative results for carcinoma that is acceptable, the proportion of adenomas (which bleed less than carcinomas) that one wishes to detect, the proportion of false positive results that is acceptable, and the cost of testing samples. The costs of the immunological technique are of the same order as Hemoccult II and the time taken to carry it out 'en masse' is about 5 minutes per subject. The data presented suggests that immunological testing for human blood in faeces is superior to chemical techniques for screening for colorectal cancer.
